NVCT (STOCKS)
Nuvectis Pharma, Inc. Common Stock
$19.510000
-0.030000 (-0.15%)
Prev close: $19.540000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ronald E. Bentsur
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $626.87M
- Employees
- 13
- P/E (TTM)
- -15.05
- P/B (TTM)
- 57.43
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Research and Development | $19.65M |
| Operating Income/Loss | -$28.87M |
| Income/Loss From Continuing Operations After Tax | -$27.85M |
| Income/Loss From Continuing Operations Before Tax | -$27.85M |
| Net Income/Loss | -$27.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$27.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$30.28M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $2.43M |
| Preferred Stock Dividends And Other Adjustments | $2.43M |
| Basic Earnings Per Share | -$1.31 |
| Diluted Earnings Per Share | -$1.31 |
| Basic Average Shares | 70,071,009 |
| Diluted Average Shares | 70,071,009 |
| Assets | $22.38M |
| Current Assets | $22.38M |
| Noncurrent Assets | $0.00 |
| Liabilities | $13.29M |
| Current Liabilities | $13.29M |
| Accounts Payable | $5.18M |
| Wages | $6.63M |
| Other Current Liabilities | $1.48M |
| Noncurrent Liabilities | $0.00 |
| Equity | $9.08M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.08M |
| Liabilities And Equity | $22.38M |
| Net Cash Flow From Operating Activities | -$19.51M |
| Net Cash Flow From Operating Activities, Continuing | -$19.51M |
| Net Cash Flow From Investing Activities | $4.63M |
| Net Cash Flow From Investing Activities, Continuing | $4.63M |
| Net Cash Flow From Financing Activities | $14.88M |
| Net Cash Flow From Financing Activities, Continuing | $14.88M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$27.85M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$27.85M |
| Other Comprehensive Income/Loss | $0.00 |